Literature DB >> 2654643

Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

G E Griffin1, K Leung, T M Folks, S Kunkel, G J Nabel.   

Abstract

The latent period of AIDS is influenced by factors which activate human immunodeficiency virus (HIV) replication in different cell types. Although monocytic cells may provide a reservoir for virus production in vivo, their regulation of HIV transcription has not been defined. We now report that HIV gene expression in the monocyte lineage is regulated by NF-kappa B, the same transcription factor known to stimulate the HIV enhancer in activated T cells; however, control of NF-kappa B and HIV in monocytes differs from that observed in T cells. NF-kappa B-binding activity appears during the transition from promonocyte to monocyte in U937 cells induced to differentiate in vitro and is present constitutively in mature monocytes and macrophages. In a chronically infected promonocytic cell, U1, differentiation is associated with HIV-1 replication as well as NF-kappa B binding activity. These findings suggest that NF-kappa B binding activity is developmentally regulated in the monocyte lineage, and that it provides one signal for HIV activation in these cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654643     DOI: 10.1038/339070a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  188 in total

1.  Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Authors:  D M Markovitz; M C Hannibal; M J Smith; R Cossman; G J Nabel
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat.

Authors:  S Winandy; B Renjifo; Y Li; N Hopkins
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

3.  Musca domestica pupae lectin improves the immunomodulatory activity of macrophages by activating nuclear factor-κB.

Authors:  Xiaohong Cao; Minghui Zhou; Chunling Wang; Lihua Hou; Yuanyuan Li; Linye Chen
Journal:  J Med Food       Date:  2011-12-22       Impact factor: 2.786

4.  Characterization of the human 5-lipoxygenase gene promoter.

Authors:  S Hoshiko; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Comparison of constitutive and inducible transcriptional enhancement mediated by kappa B-related sequences: modulation of activity in B cells by human T-cell leukemia virus type I tax gene.

Authors:  F Mauxion; C Jamieson; M Yoshida; K Arai; R Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Octamer-binding proteins in diverse hemopoietic cells.

Authors:  P N Cockerill; S P Klinken
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

7.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.

Authors:  Levente József; Christine Zouki; Nicos A Petasis; Charles N Serhan; János G Filep
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

9.  Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Authors:  Olaf Kutsch; Etty N Benveniste; George M Shaw; David N Levy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.